The potential threats of Anthropic Mythos to the NHS

Nelson Advisors

38 minutes ago12 min read

How will OpenClaw impact Healthcare Technology in 2026?

Nelson Advisors

2 hours ago11 min read

Evolution of the European HealthTech and MedTech Advisory Ecosystem: Rise of Founder Bankers and Specialist Boutiques

Nelson Advisors

2 days ago11 min read

Commonwealth Growth Strategies for UK and European HealthTech companies

Nelson Advisors

2 days ago13 min read

This Week in European MedTech and HealthTech: 17th April 2026

Nelson Advisors

3 days ago5 min read

The Horizontal Enabling Layer: Structural Disruption and the Reconfiguration of Healthcare AI Moats

Nelson Advisors

4 days ago14 min read

Practo, ZocDoc, Doctolib: Are a wave of Healthcare Appointment Booking IPOs on the Horizon?

Nelson Advisors

5 days ago14 min read

The Evolution of Amazon’s Healthcare Strategy: From Primary Care to Care Orchestration

Nelson Advisors

6 days ago14 min read

GeDIG Legislation and the Sovereignty of the German Digital Health Front Door

Nelson Advisors

7 days ago11 min read

Nelson Advisors 20 Future European HealthTech and MedTech Series 2026

Nelson Advisors

Apr 1117 min read

20 Future Slovakian HealthTech and MedTech Leaders

Nelson Advisors

Apr 1115 min read

20 Future Hungarian HealthTech and MedTech Leaders

Nelson Advisors

Apr 1114 min read

20 Future Greek HealthTech and MedTech Leaders

Nelson Advisors

Apr 1113 min read

Healthcare Business International interviews Nelson Advisors discussing Healthbridge's acquisition of AI scribe Nora

Nelson Advisors

Apr 102 min read

20 Future Estonian HealthTech and MedTech Leaders

Nelson Advisors

Apr 1014 min read

This Week in European MedTech and HealthTech: 10th April 2026

Nelson Advisors

Apr 105 min read

20 Future Czech HealthTech and MedTech Leaders

Nelson Advisors

Apr 916 min read

20 Future Portuguese HealthTech and MedTech Leaders

Nelson Advisors

Apr 814 min read

20 Future Swiss HealthTech and MedTech Leaders

Nelson Advisors

Apr 813 min read

Biological Intelligence: Strategic Rationale for Anthropic's $400 Million Acquisition of Coefficient Bio

Nelson Advisors

Apr 611 min read